Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01735578 · ClinicalTrials.gov registry record
Splanchnic Tissue Oxygenation During Enteral Feedings in Anemic Premature Infants at Risk for Necrotizing Enterocolitis
A clinical trial of Necrotizing Enterocolitis and Anemia of Prematurity, sponsored by University of Utah.
- Completed
- Registry status
- 52
- Enrollment target
- 1
- Study location
NCT01735578: Completed study of Necrotizing Enterocolitis and Anemia of Prematurity, sponsored by University of Utah.
NCT01735578 is a study of Necrotizing Enterocolitis and Anemia of Prematurity that has completed, run by University of Utah. The registered enrollment target is 52 participants, below the 309-participant average among 14 other Necrotizing Enterocolitis trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01735578, a study of Necrotizing Enterocolitis and Anemia of Prematurity, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency encountered in the newborn intensive care unit and represents a significant cause of morbidity and mortality in infants born prematurely. Among possible risk factors, a strong association between elective RBC transfusions in premature infants with anemia and the subsequent development of NEC has been consistently observed (6-11). However, a significant (and increasing) number of VLBW infants with anemia are managed with erythropoiesis stimulating agents (such as Epo) and iron and do not receive RBC transfusions during their hospital stay. The present study proposes to study this particular group of VLBW infants that remain with low (\<28 %) hematocrit while receiving full enteral feedings. The investigators hypothesize that significant anemia in VLBW infants will be associated with a baseline low cerebro-splanchnic oxygenation ratio (CSOR) (\<0.75) as measured by NIRS, and that nasogastric feedings (NGF) in those particular patients will lead to further decreased splanchnic oxygenation. The investigators further postulate that CSOR values will be significantly lower among VLBW that develop NEC as compared to infants that do not.
Primary Outcome
Stable premature infants who are being fed but have hematocrits lower than or equal to 28 will be continuously monitored using near-infrared spectroscopy (NIRS) in the cerebral and mesenteric regions for 24 hours.
Conditions Studied
Study Locations (1)
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2012-10 |
| Est. Completion | 2015-04 |
What the finished NCT01735578 record still lists
NCT01735578 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 309-participant average among 14 other Necrotizing Enterocolitis trials with a reported enrollment target (83% lower).
The record links to 2 conditions, with Necrotizing Enterocolitis appearing as the primary indexed condition, and to 0 interventions.
NCT01735578 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT01735578 about?
NCT01735578 is a clinical study titled "Splanchnic Tissue Oxygenation During Enteral Feedings in Anemic Premature Infants at Risk for Necrotizing Enterocolitis". Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency encountered in the newborn intensive care unit and represents a significant cause of morbidity and mortality in infants born prematurely. Among possible risk factors, a strong association between elective RBC transfusions ...
What is the current status of trial NCT01735578?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2012-10. Estimated completion is 2015-04.
What conditions does trial NCT01735578 study?
This clinical trial studies the following conditions: Necrotizing Enterocolitis, Anemia of Prematurity.
Who is sponsoring clinical trial NCT01735578?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01735578 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Necrotizing Enterocolitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01735578's enrollment target sits among peer trials
52 12th of 14 higher than 3 of 14 other Necrotizing Enterocolitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Necrotizing Enterocolitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Predictors of Necrotizing Enterocolitis in Neonates
RECRUITING
-
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis
RECRUITING · Phase 1
-
Early Routine vs. Selective Human Milk Fortification in Extremely Preterm Infants
RECRUITING · NA
-
A Cohort Study of the Intestinal Microbiota of Premature Infants
ACTIVE NOT RECRUITING
-
IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study
ACTIVE NOT RECRUITING · Phase 3
-
RBC Irradiation, Anemia and Gut Injury
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia